Nanomedicine strategies to target coronavirus
With the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, the middle east respiratory syndrome CoV (MERS-CoV) in 2012 and the recently discovered SARS-CoV-2 in December 2019, the 21st first century has so far faced the outbreak of three major coronaviruses (CoVs). In particular, SAR...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12717
- Acceso en línea:
- https://doi.org/10.1016/j.nantod.2020.100961
http://hdl.handle.net/20.500.12010/12717
- Palabra clave:
- Coronavirus
SARS-CoV-2
Nanomedicine
Vaccine
Nasal Drug Delivery
Virus-mimicking Nanoparticles
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Nanoparticle-based
- Rights
- License
- Abierto (Texto Completo)